Skip to content
Search

Latest Stories

Pharmacists urge Keir Starmer to appoint medicine supply Tsar to address growing shortage crisis

Pharmacists urge Keir Starmer to appoint medicine supply Tsar to address growing shortage crisis

Recent analysis by the NPA revealed that the number of SSPs issued by the Department of Health when medicine shortages are most acute has more than tripled in the past two years

Community pharmacists are calling on the new Labour government led by Keir Starmer to appoint a medicine supply Tsar to address the worsening medicine shortage crisis, as recent polling reveals that around three in ten patients have experienced difficulties obtaining medicines they need.


The National Pharmacy Association (NPA), representing independent community pharmacies, has stressed the need for a 'medicine shortages Tsar' to get a grip on the problem that has blighted both patients and pharmacies in recent years.

A YouGov survey commissioned by the NPA found that in the past year, 28 per cent of people were unable to collect a prescription from their local pharmacy due to medicine shortages.

Among those affected, 6 per cent experienced this 3-4 times, and 5 per cent encountered it five times or more in the last year alone. Of these patients, 32 per cent reported that the shortages had adversely affected their health, with 7 per cent  stating it had a 'great deal' of impact and 25 per cent noting a 'fair deal' of impact.

The NPA emphasised that the proposed Tsar would be responsible for investigating the robustness of the UK's medicine supply chain and enhancing the country's competitiveness in the global medicines market.

Further, the association noted that this role would ideally be filled by an independent expert with technical knowledge of medicine supply, capable of bringing together a wide range of industry organisations to tackle this complex problem.

Recent analysis by the NPA revealed that the number of Serious Shortage Protocols (SSPs), issued by the Department of Health when shortages are most acute, has more than tripled in the past two years. 78 per cent of all SSPs were issued between 2022 and 2024.

SSPs have been issued for a diverse range of medication treating conditions including; cystic fibrosis, angina, menopause symptoms, whooping cough, chest infections, contraception, depression, epilepsy, thyroid problems and anaphylaxis among many others.

Paul Rees, CEO of NPA, said: “These are incredibly worrying statistics which shows the current crisis in medicine supply is having a serious impact on people’s health.

“Although for some, a medicine shortage is frustrating and inconvenient, for others it can be potentially life threatening and have a drastic impact on how a patient can live their life.  We have seen this with the most recent shortages relating to Creon, which can be used to help those living with cystic fibrosis digest food.

“That is why we are urging the new government to appoint a medicine shortages Tsar to use this opportunity to bring together all bodies to tackle this growing and complex crisis once and for all.”

Due to shortages, pharmacies are often forced to spend hours sourcing alternative medications, driving up the cost of drugs.

Some pharmacists have reported to the NPA that ordering short-supply medications, including treatments for common conditions such as hay fever, can cost them 3 to 27 times more than the original price.

The pressure on community pharmacies is further exacerbated by a 40 per cent reduction in their funding, leading to the closure of 10 pharmacies per week so far this year.

“Medicine shortages heap pressure on already stretched community pharmacies, who have to pay inflated prices for medicines in short supply, spend hours trying to find supplies and sometimes face the heartbreaking situation of having to turn patients away,” Paul said.

More For You

Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less